Cargando…
Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
Trabectedin (ET743, Yondelis(®), manufactured by Baxter Oncology GmbH, Halle/Westfalen, Germany, for Janssen Products, LP, Horsham, PA), derived from the marine ascidian, Ecteinascidia turbinata, is a natural alkaloid with multiple complex mechanisms of action. On 23 October 2015, 15 years after the...
Autores principales: | Gordon, Erlinda M., Sankhala, K. Kumar, Chawla, Neal, Chawla, Sant P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939148/ https://www.ncbi.nlm.nih.gov/pubmed/27234989 http://dx.doi.org/10.1007/s12325-016-0344-3 |
Ejemplares similares
-
Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015) -
Trabectedin for soft tissue sarcoma
Publicado: (2021) -
The Role of Trabectedin in Soft Tissue Sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2022) -
The value of trabectedin in the treatment of soft tissue sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2016) -
Role of trabectedin in the treatment of soft tissue sarcoma
por: Christinat, Alexandre, et al.
Publicado: (2009)